Ads
related to: pfizer stock price- Trade
Buy, sell, track the market.
Discover our investment products.
- Ranked #1 in Research
Kiplinger's Best Online Brokers
Annual Review from August 31, 2023
- Learn How To Trade
We can help you invest with speed
& accuracy at every step of a trade
- Open an Account
Choose The Account That Works
Best For You, and Start Investing
- Trade
Search results
This Hormel Foods Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - Hormel Foods...
Benzinga· 4 days agoPiper Sandler analyst Brent Bracelin upgraded the rating for Asana, Inc. ASAN from Underweight to Neutral, but slashed the price target from $18 to $16. Piper Sandler analyst ...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks via Yahoo Finance· 16 hours agoGSK shares decline more than 7% in pre-market trading on Monday in response to an unfavorable ruling...
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...
Benzinga· 4 days agoOn Friday, Pfizer Inc PFE released longer-term follow-up results from the Phase 3 CROWN trial...
Obesity Drug Stocks: Where to Invest Now
Morningstar· 7 days agoThe challenge is that both stocks currently trade in overvalued territory, according to Morningstar analysts. “We think current share prices do not...
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
Investor's Business Daily· 11 hours agoOn Friday, U.S. District Court Judge Richard Andrews denied United Therapeutics' request for a...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 4 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
NVIDIA is a shoo-in for the Dow post stock split By Investing.com
Investing.com· 4 days agoThe split, which will be distributed at the close on June 7th, will give shareholders ten shares in...
Why Is Sarepta Therapeutics Stock Trading Lower On Tuesday? - Sarepta Therapeutics (NASDAQ:SRPT)
Benzinga· 7 days agoAlso Read: Second Death – Pfizer Reports Young Boy’s Death After One Year Of Gene Therapy Treatment...
Ginkgo Bioworks Stock: Bull vs. Bear
Motley Fool via Yahoo Finance· 4 days agoI suspect Ginkgo will be forced to conduct a reverse stock split to boost its share price. Buy or avoid Ginkgo Bioworks stock? Should ...
Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount
InvestorPlace· 2 days agoWhile macro-related issues are a factor, it’s company-specific issues that play a more significant...